Factors associated with referral for polysomnography in children with Down syndrome

Poornima R Wijayaratne1, Katrina Williams2, Margot J Davey3

  • 1Department of Paediatrics, Monash University, Melbourne, Australia.

Sleep Medicine
|April 20, 2021
PubMed

Insights

Many children with Down syndrome (DS) have obstructive sleep apnea (OSA), yet not all receive recommended polysomnography (PSG) screening. Community-recruited DS children without referrals showed similar OSA rates to those clinically referred, highlighting the need for universal PSG screening.

Area of Science:

  • Pediatric Sleep Medicine
  • Genetics and Rare Diseases
  • Clinical Research

Background:

  • Children with Down syndrome (DS) have a high prevalence of obstructive sleep apnea (OSA).
  • Polysomnography (PSG) is recommended for DS children by age four, but compliance with referrals is incomplete.
  • Understanding referral patterns is crucial for improving OSA diagnosis in this population.

Purpose of the Study:

  • To compare demographics, PSG results, OSA severity, behavior, daytime functioning, and quality of life (QOL) between children with DS referred for sleep testing and those from the community.
  • To assess the impact of clinical referral on OSA diagnosis and associated outcomes in children with DS.

Main Methods:

  • A comparative study included 20 children with DS referred for OSA assessment and 24 community volunteers (ages 3-19).
  • Data collected included demographic and anthropometric measures, PSG parameters, and validated questionnaires for sleep symptoms, QOL, behavior, and daytime functioning.
  • Statistical comparisons were made between the clinically referred and community groups.

Main Results:

  • Obstructive sleep apnea (OSA) severity was similar between groups, with 50% of the clinical group and 42% of the community group having moderate/severe OSA.
  • The clinically referred group exhibited higher weight and obesity indicators (BMI z-score, waist/hip circumference, neck-to-waist ratio).
  • No significant differences were found in QOL, behavior, daytime functioning, or sleep symptom scores between the groups.

Conclusions:

  • A substantial proportion (42%) of children with DS recruited from the community had moderate/severe OSA, despite not being clinically referred.
  • Similar QOL, behavior, and daytime functioning outcomes were observed across groups, even with differing obesity metrics.
  • These findings emphasize the critical importance of universal PSG screening for all children with Down syndrome to ensure timely OSA diagnosis and management.
Abstract